Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Kingfa Science

₹1982 -18.7 | 0.9%

Market Cap ₹2400 Cr.

Stock P/E 19.1

P/B 4.3

Current Price ₹1982

Book Value ₹ 458.3

Face Value 10

52W High ₹2595.1

Dividend Yield 0%

52W Low ₹ 1400

Kingfa Science Research see more...

Overview Inc. Year: 1983Industry: Plastic Products

Kingfa Science & Technology (India) Ltd, previously Hdro S & S Industries Ltd, is engaged within the manufacturing of modified thermoplastics enterprise. The Company operates thru Reinforced Polypropylene segment. It manufactures and supplies Thermoplastics Elastomers, Fiber Re-Inforced composites and Reinforced Polypropylene Compounds. Its Polypropylene is modified by means of the addition of reinforcements, consisting of talc, chalk, mica and glass fiber to be used as a steel alternative in engineering applications. It manufactures various thermoplastic elastomers underneath the HYPRENE brand name. The Company's merchandise and substances are utilized in electronic equipment, industrial gadget, automobile, consumer goods, packaging and toys, amongst others. Its production centers are positioned at Pudukkottai in Tamil Nadu; Puducherry; Jejuri in Pune, and Manesar in Delhi. The Company has a total compounding capability of approximately 35,000 million metric lots annually (MTA).

Read More..

Kingfa Science Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Kingfa Science Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 265 256 304 346 351 339 366 339 351 394
Other Income 0 0 0 0 1 2 1 2 0 2
Total Income 265 257 305 346 352 342 366 341 351 396
Total Expenditure 251 243 287 338 317 310 311 289 306 357
Operating Profit 14 14 17 8 35 32 55 52 45 39
Interest 1 1 2 1 1 1 2 1 1 1
Depreciation 3 3 3 3 4 4 4 4 4 5
Exceptional Income / Expenses 0 0 -6 0 0 0 0 0 0 0
Profit Before Tax 10 10 5 3 30 27 49 47 40 32
Provision for Tax 3 3 1 1 8 7 13 12 10 8
Profit After Tax 7 7 4 2 22 20 37 35 30 24
Adjustments 0 -0 0 0 -0 0 0 0 -0 -0
Profit After Adjustments 7 7 4 2 22 20 37 35 30 24
Adjusted Earnings Per Share 6.1 6.2 3.3 2 18.2 16.7 30.2 28.9 24.4 20.1

Kingfa Science Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 157 178 219 314 427 602 702 742 627 1048 1404 1450
Other Income 1 0 0 1 4 6 4 3 10 1 2 5
Total Income 157 178 219 315 431 607 706 744 638 1049 1406 1454
Total Expenditure 155 181 212 288 408 560 666 698 612 966 1276 1263
Operating Profit 3 -3 7 28 23 47 40 46 26 83 130 191
Interest 7 7 8 7 2 2 2 4 3 5 7 5
Depreciation 3 3 3 3 3 6 8 9 11 13 14 17
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 -23 0 0
Profit Before Tax -7 -12 -5 17 18 39 29 33 12 41 110 168
Provision for Tax -2 -4 -2 7 5 14 10 9 7 11 28 43
Profit After Tax -5 -8 -3 11 12 25 19 25 5 31 81 126
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments -5 -8 -3 11 12 25 19 25 5 31 81 126
Adjusted Earnings Per Share -7.3 -12.3 -4.4 10.5 12.3 20.3 15.7 20.3 4.4 25.3 67.2 103.6

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 34% 24% 18% 24%
Operating Profit CAGR 57% 41% 23% 46%
PAT CAGR 161% 48% 27% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 18% 37% 27% 44%
ROE Average 19% 10% 8% -3%
ROCE Average 25% 13% 12% 9%

Kingfa Science Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 20 11 8 119 244 305 324 349 354 385 466
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 4 15 15 16 16 16 17 18 24 17 0
Other Non-Current Liabilities 1 -3 -4 0 3 5 4 2 8 8 5
Total Current Liabilities 60 79 101 95 142 160 206 227 284 471 539
Total Liabilities 85 102 120 230 405 485 551 596 671 880 1010
Fixed Assets 26 24 25 29 76 88 85 107 129 126 123
Other Non-Current Assets 1 1 2 43 13 9 94 128 136 142 149
Total Current Assets 58 77 93 158 316 388 372 362 407 612 738
Total Assets 85 102 120 230 405 485 551 596 671 880 1010

Kingfa Science Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 0 0 2 1 1 13 2 4 9
Cash Flow from Operating Activities 9 -24 -1 19 -119 -116 96 30 -2 38 27
Cash Flow from Investing Activities 2 -1 -4 -47 -18 -6 -77 -63 -14 -19 -24
Cash Flow from Financing Activities -11 25 5 34 137 162 -7 22 17 -14 -9
Net Cash Inflow / Outflow 0 0 0 6 -1 40 12 -11 1 5 -6
Closing Cash & Cash Equivalent 0 0 0 7 1 41 13 2 4 9 2

Kingfa Science Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) -7.34 -12.33 -4.42 10.45 12.27 20.35 15.73 20.33 4.39 25.29 67.22
CEPS(Rs) -3.24 -8.46 0.14 13.29 15.29 25.48 22.35 27.72 13.31 36 78.9
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 28.89 16.57 11.87 115.56 129.83 252.09 267.94 287.84 292.29 317.57 384.78
Core EBITDA Margin(%) 1.05 -1.65 2.62 7.48 4 6.67 5.02 5.84 2.47 7.82 9.12
EBIT Margin(%) -0.07 -2.87 1.39 6.91 4.11 6.58 4.5 4.98 2.42 4.45 8.27
Pre Tax Margin(%) -4.03 -6.16 -1.9 4.88 3.66 6.25 4.17 4.5 1.89 3.95 7.81
PAT Margin (%) -2.86 -4.25 -1.23 3.03 2.57 3.99 2.72 3.32 0.85 2.92 5.8
Cash Profit Margin (%) -1.26 -2.92 0.04 3.86 3.2 5 3.86 4.53 2.57 4.16 6.81
ROA(%) -5.84 -9.07 -2.73 6.16 3.91 5.54 3.68 4.29 0.84 3.95 8.61
ROE(%) -22.55 -54.24 -31.12 16.93 9.9 11.29 6.05 7.31 1.51 8.3 19.14
ROCE(%) -0.22 -8.95 4.38 22.47 9.44 13.27 9.46 10.04 3.72 11.02 24.98
Receivable days 70.42 73.77 76.17 72.38 81.19 91.8 101.62 100 118.9 86.17 83.3
Inventory Days 38.71 38.56 40.62 46.79 48.44 54.6 56.83 52.58 73.92 70.35 71.52
Payable days 53.75 62.3 64.19 89.33 98.65 93.42 104.98 115.83 142.35 136.36 147.25
PER(x) 0 0 0 52.4 62.78 43.25 42.31 18.19 132.75 50.1 19.74
Price/Book(x) 0.44 2.26 19.03 4.74 5.93 3.49 2.48 1.28 2 3.99 3.45
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.27 0.49 1.05 1.83 1.68 1.69 1.1 0.63 1.19 1.48 1.15
EV/Core EBITDA(x) 15.74 -28.28 35.02 20.89 31.24 21.68 19.43 10.25 28.87 18.66 12.44
Net Sales Growth(%) 4.32 13.57 23.04 43.59 35.95 40.86 16.6 5.7 -15.41 67.07 33.95
EBIT Growth(%) -102.06 -4226.12 160.19 614.97 -19.23 104.53 -22.23 16.76 -58.91 207.59 149.02
PAT Growth(%) 0 -67.92 64.11 455 14.85 98.66 -22.67 29.19 -78.38 475.62 165.76
EPS Growth(%) 0 -67.92 64.11 336.21 17.39 65.86 -22.67 29.19 -78.38 475.62 165.76
Debt/Equity(x) 1.73 5.45 9.24 0.13 0.32 0.07 0.05 0.13 0.19 0.11 0.08
Current Ratio(x) 0.97 0.97 0.92 1.67 2.22 2.43 1.81 1.59 1.43 1.3 1.37
Quick Ratio(x) 0.65 0.68 0.61 1.04 1.74 1.71 1.31 1.1 0.93 0.75 0.83
Interest Cover(x) -0.02 -0.87 0.42 3.41 9.17 19.91 13.32 10.4 4.58 8.82 17.78
Total Debt/Mcap(x) 3.93 2.41 0.49 0.03 0.04 0.02 0.02 0.1 0.09 0.03 0.02

Kingfa Science Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99
FII 6.33 6.35 6.34 6.32 6.32 6.33 6.34 6.35 6.36 6.33
DII 0 0 0 0 0 0 0 0 0 0
Public 18.68 18.66 18.66 18.69 18.69 18.67 18.67 18.66 18.64 18.68
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has delivered good profit growth of 26% CAGR over last 5 years
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 10% over the last 3 years.
  • Debtor days have increased from 136.36 to 147.25days.
  • Stock is trading at 4.3 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Kingfa Science News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....